RPL554 is a long-acting bronchodilator or anti-inflammatory molecule being developed to treat hay fever (rhinitis), asthma and chronic obstructive pulmonary disease.
The inhalation studies will be undertaken by Lab Research of Hungary, which is already conducting other safety studies on RPL554.